Clinical Trials Browser

Phase 3 × nilotinib × Sarcoma × Clear all

NCT03784014 2025-12-11

MULTISARC

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

NCT01289028 2017-01-02

Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.

Phase 3 Completed

125 enrolled 11 charts

GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT00751036 2014-03-26

MACS0375

Phase 3 Terminated

94 enrolled 10 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00471328 2012-06-12

ENEST

Phase 3 Completed

248 enrolled 17 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors